SCHEDULE: T. Rowe Price Discloses 10.2% Stake in Perrigo Co PLC

T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 10.2% of Perrigo Co PLC's common stock as of April 30, 2026.

Summary

• T. Rowe Price Associates, Inc. has reported beneficial ownership of 14,016,148 shares of Perrigo Co PLC common stock.
• This holding represents 10.2% of the total class of securities.
• The filing is an amendment (Amendment No. 5) to a Schedule 13G.
• The date of the event requiring this filing is April 30, 2026.
• T. Rowe Price Associates, Inc. is identified as an investment adviser.
• The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it indicates a significant investment by a reputable firm, but it does not provide operational or financial updates for Perrigo Co PLC.

Positives

• T. Rowe Price Associates, Inc., a significant investment manager, has taken a substantial stake (10.2%) in Perrigo Co PLC, which could signal confidence in the company's future prospects.
• The filing indicates that the shares were acquired in the ordinary course of business, suggesting a standard investment strategy rather than a hostile takeover attempt.

Negatives

• The filing does not contain any negative financial results or operational issues for Perrigo Co PLC; it solely reports T. Rowe Price's ownership stake.

Risks

• While not explicitly stated as a risk in this filing, a significant ownership stake by an institutional investor can lead to increased pressure on management to meet performance expectations.
• The filing does not detail specific risks related to Perrigo Co PLC's business operations or market conditions.

Future Outlook

The filing itself does not contain forward-looking statements or guidance from Perrigo Co PLC. It is a disclosure of ownership by T. Rowe Price Associates, Inc.

Management Comments

• T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied.
• By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

Industry Context

StockSavvy.ai notes that significant stake acquisitions by major investment firms like T. Rowe Price often reflect a belief in the target company's long-term value or strategic positioning within the pharmaceutical or consumer healthcare sectors, where Perrigo operates.

Stakeholder Impact

• Shareholders: The increased institutional ownership may lead to greater scrutiny and potentially influence management decisions, which could impact share price.
• Management: Perrigo's management may face increased expectations for performance and strategic execution due to the significant stake held by T. Rowe Price.

Next Steps

• T. Rowe Price Associates, Inc. will continue to hold its shares in Perrigo Co PLC, subject to its investment advisory agreements and client mandates.
• Further filings may be required if T. Rowe Price's ownership stake changes significantly.

Key Dates

Keywords

Perrigo Co PLC, T. Rowe Price Associates, Inc., Schedule 13G, Beneficial Ownership, Investment Adviser, Common Stock, SEC Filing, Institutional Investor